Nidal Jihad Moukaddam

Nidal Moukaddam practices at Harris Health Ben Taub Hospital in Houston, Texas, part of Harris County, TX.

Nidal Moukaddam's NPI, 1396854378, was assigned on August 30, 2006. Nidal Moukaddam graduated from American University of Beirut Faculty of Medicine in 1999. Nidal Moukaddam holds Texas license M0833.

Nidal Moukaddam's primary practice is Harris Health Ben Taub Hospital, at 1504 Taub Loop, Houston, TX 77030 in Harris County. The practice phone is (713) 873-2000.

Nidal Moukaddam's primary practice is Harris Health Ben Taub Hospital in Houston, Texas, part of Harris County, TX. The medical group on file is Baylor College of Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Nidal Moukaddam practices. Vendor and product names are available with a free account.

Psychiatry is Nidal Moukaddam's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Nidal Moukaddam is board certified in addiction medicine by the American Board of Preventive Medicine. Nidal Moukaddam is licensed in Texas.

Dmand AI lists anxiety, depression, drug use disorders and schizophrenia among the conditions Nidal Moukaddam treats.

CMS data shows 15 Medicare services from Nidal Moukaddam across 1 procedure code in 2024, for 36 Medicare patients. Medicare paid $1,421 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 36 Medicare patients who saw Nidal Moukaddam in 2024. The largest group is under 65, with 23 patients. 75% of them have anxiety, and 75% have depression. 56% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nidal Moukaddam's median patient age at 49, with 44% women.

In 2024, Nidal Moukaddam wrote 211 Medicare Part D claims for 17 patients. 96% of them were for generic drugs. CMS names the drug for 120 of them, across 7 drugs with 11 or more claims each, at $3,286 in total drug cost. In 2023, CMS named 113 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Nidal Moukaddam for performance year 2024, reported as part of a group. Nidal Moukaddam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Nidal Moukaddam as offering telehealth.

Dmand AI links 33 papers to Nidal Moukaddam, published from 2008 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Emergency Service, Hospital, Emergency Services, Psychiatric and Emergencies. Nidal Moukaddam has published most often in Psychiatr Clin North Am. Nidal Moukaddam's most frequent co-authors are Veronica T. Tucci, MD, Anu A. Matorin, MD and Asim A. Shah, MD.

Dmand AI links Nidal Moukaddam to 1 clinical trial. Open Payments lists research payments to Nidal Moukaddam that name 1 trial.

CMS Open Payments shows 20 general payments to Nidal Moukaddam from 3 drug and device companies from 2016 to 2023. Travel and lodging make up the largest share, 76% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $1,554. It also lists 4 research payments totaling $1,550 in 2019, naming 1 clinical trial.

Nidal Moukaddam graduated from American University of Beirut Faculty of Medicine in 1999.

Nidal Moukaddam is in network with 5 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and CMS Medicare. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.